Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1861-1870 Newer>

The Motley Fool March 15, 2005 Charly Travers	PDL Eyeing Up Profits A timely acquisition is paying off for this drug maker. Investors, take note.
The Motley Fool March 15, 2005 Stephen D. Simpson	IVAX Is No Placebo The maker of generic drugs moves higher on fourth-quarter results that surprised Wall Street.
BusinessWeek March 21, 2005 Catherine Arnst	On The Hot Seat At Biogen How Biogen CEO Jim Mullen managed a drug crisis after alarming news broke that the multiple sclerosis drug Tysabri may cause a deadly brain infection.
The Motley Fool March 11, 2005 Karl Thiel	Better Times at Biogen IDEC Is now the time to buy this pharmaceutical?
BusinessWeek March 21, 2005 Gene G. Marcial	HealthTronics, A Urologist's Best Friend Shares of little-known largest provider of urological services have been on fire, bolting from $6.32 in October to $10.40 on Mar. 9.
The Motley Fool March 10, 2005 Bill Mann	Bad Trade at Biogen IDEC An executive resigns as regulators look into a stock sale.
The Motley Fool March 9, 2005 Lawrence Meyers	Pediatrix Misses by a Heartbeat A small earnings miss hits Pediatrix stock, but the pediatric critical care provider is healthier than it looks.
The Motley Fool March 9, 2005 Stephen D. Simpson	The Merits of Merit Medical Living in the gaps created by the big boys is risky for small medical device makers, but it can pay off over time. Merit Medical could hold some merit for patient value portfolios.
The Motley Fool March 9, 2005 W.D. Crotty	WebMD's Misleading Results WebMD reports good numbers, but the stock looks pricey.
The Motley Fool March 9, 2005 Brian Gorman	Sanofi's Answer to Obesity Sanofi-Aventis will ask for FDA approval of an exciting new drug that may work for a variety of addictions.
<Older 1861-1870 Newer> Return to current articles.